Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada

AIM: Clinical trials and real-world data for Type 2 diabetes have shown that real-time continuous glucose monitoring (rt-CGM) lowers glycated hemoglobin (A1c) and reduces hypoglycemia relative to self-monitoring of blood glucose (SMBG). This analysis examined the long-term health and economic outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshannaq, Hamza, Isitt, John J, Pollock, Richard F, Norman, Gregory J, Cogswell, Greg, Lynch, Peter M, Roze, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Becaris Publishing Ltd 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690435/
https://www.ncbi.nlm.nih.gov/pubmed/37668608
http://dx.doi.org/10.57264/cer-2023-0075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690435/
https://www.ncbi.nlm.nih.gov/pubmed/37668608
http://dx.doi.org/10.57264/cer-2023-0075

Ejemplares similares